It is also possible that patients who developed CM-IRIS had aberrant or dysregulated CD4+ T cell function during the primary cryptococcal infection resulting in persistent cryptococcal antigen, known to be a risk factor for CM-IRIS [27,31]. The gene discussed is CD4; the disease is cutaneous mastocytosis.